Pharmaceutical and Biotech Insight, News and Blog Posts

DelveInsight Blog

Map the latest in Pharmaceutical, Healthcare, Medical Devices and Biotech Space with DelveInsight’s panoramic market analysis while the Pharma Industry continues to rapidly evolve with several approvals,failures, acquisitions, and partnerships teeing up the domain.

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Continue to Adorn the ...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal infection that leads to discoloration and thickening of the nail plate. It is four to seven times more frequent in toenails, where it often involves several nails. It is a progressive disease and may become widely spread to other nails, body...

onychomycosis-market-CAGR-size-share-trends-growth-population-epidemiology-therapy-therapeutics-treatment

Follicular Lymphoma Market Size Anticipates Growth as the Key Companies Explores Novel Therapeuti...

Follicular lymphoma, a sub-type of indolent B cell non-Hodgkin lymphoma (NHL), accounts for approximately 20% of the total NHL cases. It is the most frequently diagnosed indolent lymphoma. On average, each year, 15,000 new Follicular lymphoma cases are diagnosed in the US alone. DelveInsight estimated that in 2020 there were ...

follicular-lymphoma-market-size-share-trends-growth-cagr-population-epidemiology-therapy-therapeutics-treatment

Series of FDA’s Approvals in ALS Drdeservesymphoma Space; Roche, Temedica Forges Digital Compani...

FDA’s Go-Ahead to Amylyx New Drug Application for ALS Drug  Amylyx Pharmaceuticals has announced its plan to submit a New Drug Application (NDA) to the U.S. FDA for its drug, AMX0035 (sodium phenylbutyrate (PB) and Taurursodiol (TURSO)), for the treatment of Amyotrophic lateral sclerosis (ALS).  A few months ago, th...

pharma-happenings-for-amylyx-beigene-roche-temedic-sage-therapeutics
venous-thromboembolism-market-size-share-trends-companies-cagr-growth-therapy-treatment-therapeutics
Venous Thromboembolism Market Growth Quadrant t...

Venous thromboembolism (VTE) is a condition that is characterized by the development of...

major-depressive-disorder-key-companies-emerging-therapies-market-cagr-trends-size-share-growth-forecast
Major Depressive Disorder Market Quadrant Growt...

Depression is a common and serious medical condition that affects the way people behave...

primary-hyperoxaluria-market-cagr-size-share-trends-growth-and-key-companies
Primary Hyperoxaluria Market Size Observes Grow...

Primary hyperoxaluria (PH) is a rare autosomal genetic form of Hyperoxaluria, a conditi...

Our Consulting Services

Optimized, competent, and dependable solutions to tackle fast-paced pharma market challenges.

Our Consulting Services
Our Pharma Market Reports

Credible, data-driven, and analytical pharma and biotech market research and analysis for a holistic understanding.

Our Pharma Market Reports
Our MedTech Insights

Clinical solutions for vastly expanding diagnostics, digital therapeutics, and the MedTech industry.

Our MedTech Insights
Editor's Pick
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against C...

Cancer is a leading cause of global death, accounting for nearly 10 million deaths in 2...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...

Unity’s advanced vascular eye disease trial; Rallybio raises $100 M; Sa...

UNITY Biotechnology declares positive data from phase 1 clinical trial of UBX1325 in Ad...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.